A study published earlier this month in the journal Science Progress found that GLP-1 drugs were linked to hair loss in patients during periods of fast weight loss
It all points in the same direction: less joint pain, fewer flares, lower cardiovascular risk, better response to existing medications
They create repeatable, defensible playbooks Redesign Health and PE-backed operators take something like GLP-1 clinic and turn it into a systematized unit economics
It increases pyloric sphincter tone, making it harder for food to pass from stomach to small intestine
Then, the researchers administered exendin-4 via intrathecal injection to the experimental rats and observed a reduction in pain sensitivity, alleviation of neural inflammation, and suppression of inflammatory factors such as IL-1, TNF-, and iNOS
SARAH CARSTENS: So we have not had any patients who have specifically been on this medication that have been reporting significant changes to their use patterns, though it absolutely has been a topic of conversation, just people hearing that this is something thats happening and wondering, is this something that could be helpful for them in the future
